Gang Wu

Gang Wu

Auto-generated profile, based on publicly available information

Gang Wu

National Institutes for Food and Drug Control, NHC Key Laboratory of Research on Quality and Standardization of Biotech Products, NMPA Key Laboratory for Quality Research and Evaluation of Biological Products, Beijing 102629, China; State Key Laboratory of Drug Regulatory Science, Beijing 102629, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2023 in Analytical Chemistry
Verified
Journal Article
Closed access
GWGang Wu
Gang Wu
CYChuanfei Yu
Chuanfei Yu
WWWenbo Wang
Wenbo Wang
JDJialiang Du
Jialiang Du
ZFZhihao Fu
Zhihao Fu
LWLan Wang
Lan Wang

30 September 2024 in Electrophoresis
Verified
Journal Article
Closed access
PDF file
XZXiaoxi Zhang
Xiaoxi Zhang
GWGang Wu
Gang Wu
MDMin Du
Min Du
TBTao Bo
Tao Bo
TCTong Chen
Tong Chen
THTiemin Huang
Tiemin Huang


8 September 2024 in Journal of Chromatography A
Verified
Journal Article
Closed access
GWGang Wu
Gang Wu
XZXiaoxi Zhang
Xiaoxi Zhang
XWXin Wang
Xin Wang
JDJialiang Du
Jialiang Du
MLMeng Li
Meng Li
YCYu Chuanfei
Yu Chuanfei

2 July 2025 in Medcomm
Verified
Journal Article
Open access
GWGang Wu
Gang Wu
CYChuanfei Yu
Chuanfei Yu
CDChunyong Ding
Chunyong Ding
SYShengtao Yao
Shengtao Yao
JDJialiang Du
Jialiang Du
JWJun-Zhi Wang
Jun-Zhi Wang
Recently, rapidly evolving STING‐based immunotherapies have offered novel therapeutic options for various cancer types. However, systemic administration of STING agonists raises safety concerns, and intratumoral injection is constrained by tumor accessibility. Herein we developed an immune‐stimulating antibody conjugate (ISAC) that links STING agonists to antibodies that target HER2‐positive tumor cells via a cleavable linker. In vivo studies demonstrated that the STING agonist ISAC is well tolerated and exhibits potent antitumor activity in syngeneic mouse tumor models. Investigations in STING‐knockout HER2‐positive tumor cells and STING‐knockout mouse models revealed that the STING pathway primarily mediates antitumor effects upon the activation of immune and tumor cells and that the activation of immune cells plays a stronger role. Additionally, our findings indicate that the STING agonist ISAC enhances both innate and adaptive antitumor immune responses, leading to sustained antitumor activity and the establishment of immune memory. These outcomes support the clinical development of the STING agonist ISACs.

8 July 2024 in Electrophoresis
Verified
Journal Article
Closed access
GWGang Wu
Gang Wu
JDJialiang Du
Jialiang Du
GXGangling Xu
Gangling Xu
MLMeng Li
Meng Li
CYChuanfei Yu
Chuanfei Yu